BriaCell Therapeutics Corp (BCTX)
0.5996
-0.05
(-7.75%)
USD |
NASDAQ |
Nov 13, 16:00
0.601
0.00 (0.00%)
After-Hours: 20:00
BriaCell Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
January 30, 2024 | 25.25 |
January 29, 2024 | 25.13 |
January 26, 2024 | 23.49 |
January 25, 2024 | 23.26 |
January 24, 2024 | 23.08 |
January 23, 2024 | 23.61 |
January 22, 2024 | 24.72 |
January 19, 2024 | 24.37 |
January 18, 2024 | 25.84 |
January 17, 2024 | 26.07 |
January 16, 2024 | 24.43 |
January 12, 2024 | 25.78 |
January 11, 2024 | 24.96 |
January 10, 2024 | 26.13 |
January 09, 2024 | 28.42 |
January 08, 2024 | 31.54 |
January 05, 2024 | 31.65 |
January 04, 2024 | 31.30 |
January 03, 2024 | 29.36 |
January 02, 2024 | 31.36 |
December 29, 2023 | 34.35 |
December 28, 2023 | 32.12 |
December 27, 2023 | 30.83 |
December 26, 2023 | 30.48 |
December 22, 2023 | 25.72 |
Date | Value |
---|---|
December 21, 2023 | 23.55 |
December 20, 2023 | 23.96 |
December 19, 2023 | 23.14 |
December 18, 2023 | 24.25 |
December 15, 2023 | 24.25 |
December 14, 2023 | 24.66 |
December 13, 2023 | 24.03 |
December 12, 2023 | 24.25 |
December 11, 2023 | 26.84 |
December 08, 2023 | 27.72 |
December 07, 2023 | 28.76 |
December 06, 2023 | 29.72 |
December 05, 2023 | 30.89 |
December 04, 2023 | 31.42 |
December 01, 2023 | 31.59 |
November 30, 2023 | 31.07 |
November 29, 2023 | 30.07 |
November 28, 2023 | 29.25 |
November 27, 2023 | 28.95 |
November 24, 2023 | 29.30 |
November 22, 2023 | 26.84 |
November 21, 2023 | 26.13 |
November 20, 2023 | 26.08 |
November 17, 2023 | 25.55 |
November 16, 2023 | 24.14 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.450
Minimum
May 12 2022
34.35
Maximum
Dec 29 2023
7.522
Average
4.172
Median
Sep 16 2021
Price to Book Value Benchmarks
CeCors Inc | -- |
Venus Concept Inc | 0.6567 |
Aurinia Pharmaceuticals Inc | 3.056 |
Edesa Biotech Inc | 2.492 |
Lexaria Bioscience Corp | 3.514 |
Price to Book Value Related Metrics
Price | 0.5996 |
Earnings Yield | -195.1% |
Market Cap | 21.70M |